What statements are required when submitting a Sequence Listing?

This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.

When submitting a Sequence Listing for a patent application, several statements are required according to MPEP 2427:

• A statement that the “Sequence Listing” includes no new matter
• A statement that indicates support for the amendment in the application, as filed
• A statement that the content of the CRF is identical to the “Sequence Listing” part of the disclosure

These statements are crucial for ensuring compliance with 37 CFR 1.821-1.825. For example, 37 CFR 1.825(b)(5) requires “A statement that the ‘Sequence Listing’ added by amendment includes no new matter.” Failure to provide these statements can result in non-compliance and may require correction by the applicant.